@justincalomese_bsnrn's peptide cocktail claims, fact-checked

What did @justincalomese_bsnrn actually say?

The pitch is straightforward: if you're between 30 and 50 and "not feeling the same as you did in your 20s," starting a GLP-1 medication combined with injectable vitamins will restore your energy, strip fat, and make "age nothing but a number." He specifically names "tricepitzide" (almost certainly tirzepatide) and "stomach glue type" (semaglutide), and frames them as a gateway to feeling like your "old self again." The video is also a direct funnel to a third-party telehealth link.

To his credit, he does not promise a specific number on the scale, and he does not claim these drugs are risk-free. But the framing is optimistic to the point of being misleading, and the mispronunciation of drug names on a medical professional's platform is a real concern for patient safety.

Does the science back this up?

GLP-1 receptor agonists do produce meaningful weight loss, and the energy benefits are real but indirect. The drugs work. The "cure your 30s malaise" framing does not hold up to scrutiny.

Semaglutide (Wegovy) reduced body weight by an average of 14.9% over 68 weeks in the STEP 1 trial (Wilding et al., 2021, NEJM). Tirzepatide showed even stronger results, with up to 22.5% mean weight reduction at the highest dose in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM). Those are genuinely impressive numbers. But neither trial recruited people based on "not feeling like themselves in their 30s." Participants had clinical obesity or weight-related comorbidities.

On injectable vitamins: the evidence for energy improvement from IV or injectable B-complex and amino acid blends in metabolically healthy people is thin. A 2022 Cochrane review found no reliable evidence that parenteral B12 outperforms oral supplementation in people without deficiency. The "energy" claim here is mostly vibes.

What did they get wrong (or right)?

The drug science is mostly accurate. The lifestyle framing is where things go sideways.

What he got right: GLP-1 agonists do suppress appetite (via hypothalamic GLP-1 receptor activation), promote fat loss, and can improve energy indirectly through weight reduction and better glycemic control. These are documented mechanisms, not hype.

What he got wrong, or at least oversimplified:

• Framing normal aging between 30 and 50 as a medical problem that requires pharmacological intervention conflates lifestyle factors with pathology. Fatigue and weight gain in this age range have many causes, most of which are not fixed by a GLP-1 alone.
• "Combining it with injectable vitamins" is presented as a logical stack with synergistic effects. There is no clinical trial evidence supporting this combination for energy or weight loss beyond what the GLP-1 alone produces.
• Mispronouncing both drug names ("tricepitzide," "stomach glue type") in a video designed to drive prescriptions is a patient safety issue, not a minor slip.
• The video links to a commercial telehealth platform, which is a conflict of interest that goes undisclosed.

What should you actually know?

GLP-1 medications are not anti-aging drugs, and feeling tired in your 30s is not a GLP-1 deficiency.

If you are clinically overweight or have metabolic risk factors, semaglutide or tirzepatide may be appropriate options to discuss with a licensed provider. The evidence for weight loss is strong. But these drugs carry real side effects: nausea, vomiting, pancreatitis risk, possible thyroid C-cell effects (tirzepatide carries an FDA boxed warning), and muscle mass loss during rapid weight reduction (Bilet et al., 2023, Obesity Reviews).

The "injectable vitamins" component, typically MICC (methionine, inositol, choline, cyanocobalamin) or amino acid blends, is not FDA-approved for weight loss or energy enhancement. These are compounded preparations. They are not equivalent to any approved drug. If a provider is bundling them as part of a weight loss package without explaining this distinction, that is a gap in informed consent.

Age-related fatigue and weight gain between 30 and 50 deserve a real workup: thyroid function, testosterone levels, sleep quality, dietary patterns, stress load. A GLP-1 prescription from a telehealth funnel is not a substitute for that conversation.